医药品·生物科技的製造·供给契约(2020年～2025年)

"製药与生物技术製造与供应合约" 深入分析了企业签订製造和供应协议的方式和原因。

这份经过全面修订和更新的报告提供了2019年至2025年製造和供应协议的详细资讯。

本报告提供了双方宣布的製造和供应协议的付款条款。这些数据有助于深入了解付款条款和交易的其他条款。

了解潜在合作伙伴谈判条款的弹性，可以为谈判过程提供重要的参考，从而了解条款谈判中可能出现的情况。许多中小企业寻求详细的付款条款，但在付款方式和权利转让方面，关注细节至关重要。

本报告提供了自2020年以来已宣布的製造和供应协议的完整列表，这些协议均记录在“当前协议”交易和联盟数据库中，包括可用的财务条款，以及公司及其合作伙伴向美国证券交易委员会提交的实际製造和供应协议文件的在线副本链接。

本报告的第一章提供了製造和供应协议及业务活动的指南。

第一章是对报告的介绍。第二章概述并分析了製造和供应趋势，并讨论了各种合约类型的优势。

第三章概述了製造和供应协议的结构。

第四章回顾了自2020年以来的主要製造和供应交易。交易按标题价格列出。对于涉及美国证券交易委员会 (SEC) 揭露协议的交易，可透过 "当前协议" 协议和联盟资料库的连结在线存取这些协议。

第五章提供了25家最活跃的生产和供应合约製造商的完整清单。每个合约标题都透过 "当前协议" 合作伙伴交易资料库连结到合约记录的全文线上版本，并在可用时连结到实际合约文件，方便用户按需存取每个合约记录。

第六章全面深入地回顾了自2020年以来已达成和宣布的生产和供应合同，并按公司A-Z、疗法、技术和行业（如有合同文件）进行组织。合约文件详细介绍了双方就生产和供应合约达成的实际条款。

合约目录包含自2019年以来宣布的所有生产和供应合约的完整清单。每个清单都按公司A-Z、疗法领域和技术类型组织成一个合约目录。每个合约标题都透过超连结连结到合约记录的线上版本，包括可用的实际合约文件。

本报告还包含大量图表，展示了 2020 年及以后製造和供应合约的趋势和活动。

总而言之，本报告提供了潜在合约製造商需要了解的有关製造和供应联盟的所有资讯。

主要优势

製药和生物技术行业的製造和供应协议为读者提供以下主要优势：

• 了解 2020 年及以后的交易趋势
• 浏览製造和供应交易
• 基准分析 - 确定交易市场价值
• 财务条款
• 按公司 A-Z、治疗领域和技术类型排列的合约目录
• 主要交易价值
• 最活跃的合约製造商
• 确定每笔交易的资产和交易条款
• 存取合约文件 - 深入了解合约结构
• 尽职调查 - 评估拟议交易条款是否适合您的合作伙伴
• 节省数百小时的研究时间

范围

• 本报告旨在详细了解主要製造和供应趋势及交易结构全球生物製药公司。

製药和生物技术製造与供应协议包括：

• 生物製药产业製造与供应合约趋势
• 製造与供应合约结构概述
• 涵盖製药和生物技术的製造与供应合约记录目录
• 主要製造与供应合约
• 最活跃的製造与供应合约製造商
• 主要製造与供应合作伙伴讯息

"製药和生物技术製造与供应合约" 列出了可用的合约。

• 公司 A-Z
• 标题价格
• 治疗领域
• 技术类型
• 每个合约标题都透过网页连结连结到实际的线上合约记录，方便存取每个合约文件。
• "製药和生物技术生产与供应合约" 提供对生产和供应合约记录（包括现有合约文件）的全面存取。

分析合约文件可以对以下内容进行尽职调查：

• 授予或选择哪些权利？
• 合约授予了哪些权利？
• 授予了哪些独家经营权？
• 合约的付款结构是怎样的？
• 如何审计销售和付款？
• 合约期限是怎样的？
• 合约的关键条款是如何定义的？
• 如何处理并拥有知识产权？
• 谁负责商业化？
• 谁负责开发、供应和生产？
• 如何管理保密和揭露问题？
• 争议：如何解决争议？
• 在什么情况下可以终止合约？
• 如果所有权发生变更会怎样？
• 双方约定了哪些分授权或分包条款？
• 公司需要哪些标准条款？
• 哪些标准条款似乎会因合作伙伴或交易类型的不同而有所差异？
• 公司主张哪个契约法管辖区？

目录

摘要整理

第1章 简介

第2章 製造业和供给业的交易趋势

• 简介
• 製造及供给契约定义
• 2020年以后的製造·供给契约趋势
  • 製造·供给契约的各年度转变，2020年～2025年
  • 製造·供给契约，各开发阶段，2020年～2025年
  • 製造·供给契约，各产业部门，2020年～2025年
  • 製造·供给契约，各治疗领域，2020年～2025年
  • 製造·供给契约，各技术类型，2020年～2025年
  • 製造·供给契约，各企业，2020年～2025年
• 签订製造·供给联盟契约的理由
• 製造和供给契约的未来

第3章 製造及供给契约结构概要

• 简介
• 製造及供给契约结构

第4章 -主要製造及供给契约

• 简介
• 各金额首位製造·供给契约

第5章 - 最活跃的製造·供给契约厂商主要25公司

• 简介
• 最活跃的製造·供给契约厂商前几名25公司

包含第6章 -契约名录的製造及供给契约

• 简介
• 按从2020年到2025年的契约製造及供给契约
• 交易名录
• 交易名录- 各企业製造·供给契约(AZ)
• 交易名录- 各治疗领域的製造及供给契约
• 交易名录- 科技各类型的製造及供给契约
• 调查关于公司
• 目前联盟
• 目前契约
• Current Partnering的最近的报告标题

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.

Fully revised and updated, the report provides details of manufacturing and supply deals from 2019 to 2025.

The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of manufacturing and supply deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of manufacturing and supply dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in manufacturing and supply as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of manufacturing and supply deals.

Chapter 4 provides a review of the leading manufacturing and supply deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active manufacturing and supply dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of manufacturing and supply deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the manufacturing and supply deal.

The deal directory includes a comprehensive listing of all manufacturing and supply deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply alliances.

Key benefits

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse manufacturing and supply deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by leading biopharma companies worldwide.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology includes:

• Trends in manufacturing and supply dealmaking in the biopharma industry
• Overview of manufacturing and supply deal structure
• Directory of manufacturing and supply deal records covering pharmaceutical and biotechnology
• The leading manufacturing and supply deals by value
• Most active manufacturing and supply dealmakers
• The leading manufacturing and supply partnering resources

In Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for manufacturing and supply deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2020
  • 2.3.1. Manufacturing and supply dealmaking by year, 2020-2025
  • 2.3.2. manufacturing and supply dealmaking by phase of development, 2020-2025
  • 2.3.3. Manufacturing and supply dealmaking by industry sector, 2020-2025
  • 2.3.4. Manufacturing and supply dealmaking by therapy area, 2020-2025
  • 2.3.5. Manufacturing and supply dealmaking by technology type, 2020-2025
  • 2.3.6. Manufacturing and supply dealmaking by most active company, 2020-2025
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts 2020-2025
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements, 2020-2025
• Figure 3: Manufacturing and supply deals signed at each phase of development, 2020-2025
• Figure 4: Manufacturing and supply deals by industry sector, 2020-2025
• Figure 5: Manufacturing and supply deals by therapy area, 2020-2025
• Figure 6: Manufacturing and supply deals by technology type, 2020-2025
• Figure 7: Top 25 most active manufacturing and supply dealmakers, 2020-2025
• Figure 8: Top manufacturing and supply deals by value, 2020-2025
• Figure 9: Most active manufacturing and supply dealmakers, 2020-2025